EMEA-002883-PIP03-23 - paediatric investigation plan

trimodulin (human IgM, IgA, IgG solution)

Key facts

• Active Substance:
  trimodulin (human IgM, IgA, IgG solution)
• Therapeutic area:
  Infections and infestations
• Decision number:
  P/0120/2024
• PIP number:
  EMEA-002883-PIP03-23
• Pharmaceutical form(s):
  Solution for infusion
• Condition(s) / indication(s):
  Treatment of lower respiratory tract and lung infections
• Route(s) of administration:
  Intravenous use
• Decision type:
  PM: decision on the application for modification of an agreed PIP
• Decision date:
  12/04/2024

Decision

P/0120/2024: EMA decision of 12 April 2024 on the agreement of a paediatric investigation plan and on the granting of a deferral for trimodulin (human IgM, IgA, IgG solution) (EMEA-002883-PIP03-23)

AdoptedReference Number: EMA/114596/2024